Response to Comment on: Five-year visual field outcomes of the HORIZON trial.
Montesano Giovanni, Ometto Giovanni, Ahmed Iqbal Ike K, Ramulu Pradeep Y, Chang David F, Crabb David P et al.
Search articles, concepts, and chapters
10 articles in GJC
Montesano Giovanni, Ometto Giovanni, Ahmed Iqbal Ike K, Ramulu Pradeep Y, Chang David F, Crabb David P et al.
Montesano Giovanni, Ometto Giovanni, Ahmed Iqbal Ike K, Ramulu Pradeep Y, Chang David F, Crabb David P et al.
The HORIZON trial found that glaucoma patients receiving cataract surgery with a Hydrus microstent had significantly slower visual field progression over five years compared to cataract surgery alone.
Fram Nicole R, McKee Yuri, Chang David F, Chee Soon-Phaik, Donaldson Kendall E, Crandall David A et al.
This case highlights surgical challenges in zonulopathy, showing iris-sutured IOLs can successfully manage subluxation. It emphasizes careful planning for cataract surgery in similar high-risk patients.
Palmer David J, Robin Alan L, McCabe Cathleen M, Chang David F
Multisociety experts recommend using multidose topical drugs for multiple patients until expiration and allowing patients to take home partially used meds, reducing waste and cost in ophthalmic surgery.
Malwankar Jui, Son Hyeck-Soo, Chang David F, Dun Chen, Woreta Fasika, Prescott Christina et al.
This study found immediate sequential bilateral cataract surgery (ISBCS) is rare in Medicare patients, but complication rates are similar to delayed surgery. Race, geography, and systemic/ocular comorbidities influence ISBCS use, suggesting it could improve access.
Ahmed Iqbal Ike K, Fea Antonio, Au Leon, Ang Robert E, Harasymowycz Paul, Jampel Henry D et al.
This study compared standalone Hydrus vs. iStent MIGS for open-angle glaucoma. Hydrus showed higher surgical success and greater medication reduction, suggesting it may be a more effective option.
Samuelson Thomas W, Chang David F, Marquis Robert, Flowers Brian, Lim K Sheng, Ahmed Iqbal Ike K et al.
The HORIZON study found that combining a Schlemm canal microstent with cataract surgery significantly lowered IOP and medication dependence more than cataract surgery alone in POAG patients, offering a safe, effective treatment.
Hoeh Helmut, Vold Steven D, Ahmed Iqbal K, Anton Alfonso, Rau Magda, Singh Kuldev et al.
This study found CyPass Micro-Stent implantation combined with cataract surgery for open-angle glaucoma safely reduced intraocular pressure and medication use. This offers a promising, low-complication treatment option.
Sengupta Sabyasachi, Chang David F, Gandhi Rajiv, Kenia Hemal, Venkatesh Rengaraj
This study found TASS after cataract surgery is uncommon (0.22%), generally resolves with good visual outcomes, but can lead to delayed complications like capsule contraction and PCO.
Chang David F, Tan Jeffrey J, Tripodis Yorghos
Younger age and longer axial length increase steroid response risk after cataract surgery, especially in highly myopic patients, necessitating closer IOP monitoring or alternative medications.
All 10 articles loaded